Cover Image
Read Now

Fluoroquinolones for the treatment of respiratory tract infections a review of clinical effectiveness, cost-effectiveness, and guidelines

This report aims to identify and synthesize the evidence describing the clinical effectiveness, cost-effectiveness, and evidence-based guidelines for the treatment of respiratory tract infections, including pneumonia and chronic obstructive pulmonary disease (COPD), using Fluoroquinolones

Bibliographic Details
Main Authors: Cowling, Tara, Farrah, Kelly (Author)
Corporate Authors: Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa CADTH May 6, 2019, 2019
Edition:Version 1.0
Series:CADTH rapid response report: summary with critical appraisal
Subjects:
Cost-benefit Analysis
Respiratory Tract Infections / Drug Therapy
Fluoroquinolones / Therapeutic Use
Treatment Outcome
Anti-bacterial Agents / Therapeutic Use
Practice Guidelines As Topic
Anti-bacterial Agents / Economics
Fluoroquinolones / Economics
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:This report aims to identify and synthesize the evidence describing the clinical effectiveness, cost-effectiveness, and evidence-based guidelines for the treatment of respiratory tract infections, including pneumonia and chronic obstructive pulmonary disease (COPD), using Fluoroquinolones
Physical Description:1 PDF file (49 pages) illustrations

Similar Items